The Journal of dermatology最新文献

筛选
英文 中文
A case of acquired partial anhidrosis localized on the palms.
The Journal of dermatology Pub Date : 2025-01-28 DOI: 10.1111/1346-8138.17640
Shuta Yoshitani, Toshihiro Otsuka, Shinichi Moriwaki, Atsushi Fukunaga
{"title":"A case of acquired partial anhidrosis localized on the palms.","authors":"Shuta Yoshitani, Toshihiro Otsuka, Shinichi Moriwaki, Atsushi Fukunaga","doi":"10.1111/1346-8138.17640","DOIUrl":"https://doi.org/10.1111/1346-8138.17640","url":null,"abstract":"","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A sporadic case of glomuvenous malformation harboring a novel mutation in GLMN.
The Journal of dermatology Pub Date : 2025-01-28 DOI: 10.1111/1346-8138.17634
Akari Terada, Eijiro Akasaka
{"title":"A sporadic case of glomuvenous malformation harboring a novel mutation in GLMN.","authors":"Akari Terada, Eijiro Akasaka","doi":"10.1111/1346-8138.17634","DOIUrl":"https://doi.org/10.1111/1346-8138.17634","url":null,"abstract":"","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomarkers associated with progression of infantile hemangioma: Exploratory study.
The Journal of dermatology Pub Date : 2025-01-28 DOI: 10.1111/1346-8138.17639
Ken Miyazaki, Kayo Kunimoto, Shiho Yasue, Saori Endo, Akifumi Nozawa, Michio Ozeki, Takuma Ishihara, Minako Tanaka, Nobuyuki Kakimoto, Tomohiro Suenaga, Daisuke Tokuhara, Hidenori Ohnishi, Yuri Inose, Masatoshi Jinnin
{"title":"Biomarkers associated with progression of infantile hemangioma: Exploratory study.","authors":"Ken Miyazaki, Kayo Kunimoto, Shiho Yasue, Saori Endo, Akifumi Nozawa, Michio Ozeki, Takuma Ishihara, Minako Tanaka, Nobuyuki Kakimoto, Tomohiro Suenaga, Daisuke Tokuhara, Hidenori Ohnishi, Yuri Inose, Masatoshi Jinnin","doi":"10.1111/1346-8138.17639","DOIUrl":"https://doi.org/10.1111/1346-8138.17639","url":null,"abstract":"<p><p>To identify patients with infantile hemangioma (IH) in need of early-stage treatment in this multicenter, prospective, observational study, we investigated the potential of plasma cytokines as a clinically useful marker. Plasma samples were collected at three time points from 41 patients with infantile hemangioma: baseline (days 14-60 after delivery), visit 1 (days 61-150, the proliferative phase), and visit 2 (days 151-395, the involuting phase). With a twofold or more increase in tumor volume during the baseline-visit 1 period regarded as progression, progression was seen in 15 cases (36.6%). In the first step, cytokine arrays were performed using plasma samples in five progressive and five non-progressive cases. Plasma levels of six cytokines at baseline were selected for a prediction marker of change in tumor volume during baseline-visit 1. Validation enzyme-linked immunosorbent assay indicated that the baseline growth differentiation factor 1 (GDF1) concentration tended to correlate with the proliferation ratio of total lesions or target lesion during baseline-visit 1, although without statistical significance. However, the plasma GDF1 concentrations were significantly lower in patients with a fourfold or more increase in total volume (p = 0.013). Furthermore, changes in plasma interleukin (IL)-7Rα levels showed a statistically significant inverse correlation between volume change of the target lesion during baseline-visit 1 (p = 0.0069). Our results suggest that plasma GDF1 measurement after birth is a useful marker for progression of IH. Additionally, the downregulation of IL-7Rα that begins several months after birth may also contribute to tumor growth. (UMIN-CTR: UMIN000038574).</p>","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A pediatric case of SAPHO syndrome without palmoplantar pustulosis.
The Journal of dermatology Pub Date : 2025-01-28 DOI: 10.1111/1346-8138.17646
Masato Ishikawa, Toshiyuki Yamamoto
{"title":"A pediatric case of SAPHO syndrome without palmoplantar pustulosis.","authors":"Masato Ishikawa, Toshiyuki Yamamoto","doi":"10.1111/1346-8138.17646","DOIUrl":"https://doi.org/10.1111/1346-8138.17646","url":null,"abstract":"","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143054305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center.
The Journal of dermatology Pub Date : 2025-01-27 DOI: 10.1111/1346-8138.17641
Moyuka Wada-Irimada, Takehiro Takahashi, Mana Sekine, Toshiki Okazaki, Takuya Takahashi, Tomoko Chiba, Emi Yamazaki, Kosuke Shido, Toshiya Takahashi, Masato Mizuashi, Yoshihide Asano
{"title":"Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center.","authors":"Moyuka Wada-Irimada, Takehiro Takahashi, Mana Sekine, Toshiki Okazaki, Takuya Takahashi, Tomoko Chiba, Emi Yamazaki, Kosuke Shido, Toshiya Takahashi, Masato Mizuashi, Yoshihide Asano","doi":"10.1111/1346-8138.17641","DOIUrl":"https://doi.org/10.1111/1346-8138.17641","url":null,"abstract":"<p><p>Alopecia areata (AA) is a chronic, autoimmune skin disease characterized by non-scarring hair loss. Baricitinib, a Janus kinase inhibitor (JAKi), prevents hair loss and promotes hair regrowth by inhibiting the inflammatory Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling pathway involved in cytotoxic T cell responses targeting hair follicles. The introduction of JAKi has transformed treatment against severe AA. However, treatment responses to JAKi are highly variable among patients, and the predictors of responsiveness remain insufficiently elucidated. This study aimed to identify independent predictive factors for the efficacy of baricitinib in patients with severe AA using multivariate analyses. A retrospective study was conducted on 70 severe AA patients who started baricitinib treatment at Tohoku University Hospital between July 2022 and August 2023. The primary outcome was the percentage of patients achieving a Severity of Alopecia Tool (SALT) score of ≤20 after 9 months of baricitinib treatment. Multivariate analysis assessed potential predictors of baricitinib treatment responses, including AA type, sex, age, disease duration, history of atopic dermatitis, intravenous methylprednisolone pulse (IVMP) therapy, and Clinician-Reported Outcome (ClinRO) measures for eyebrows and eyelashes. Achievement of a SALT score of ≤20 and SALT score improvement rates were used as objective variables in the multivariate analyses. Among the 70 patients completing 9 months of baricitinib treatment, 41% achieved a SALT score of ≤20. Multivariate analyses identified several independent predictors for positive outcomes, including shorter disease duration (≤4 years), history of IVMP, therapy SALT score of ≤95 at baricitinib initiation, and female sex. Further, we found differential response patterns based on AA type and sex. Specifically, AA type significantly influenced treatment responses, with ophiasis alopecia (OA) associated with the poorest improvement rate. In summary, the response to baricitinib in AA is significantly influenced by sex, AA type, disease duration, history of IVMP, and pre-treatment SALT score.</p>","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143049378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase-9 expression.
The Journal of dermatology Pub Date : 2025-01-24 DOI: 10.1111/1346-8138.17621
Sonja Dorfer, Michael Ablinger, Monika Wimmer, Julia I Hummel, Selma Ibrahimpašić, Anja Diem, Martin Laimer, Stefanie Gruner, Josefina Piñón Hofbauer, Christina Guttmann-Gruber, Ulrich Koller, Iris K Gratz, Johann W Bauer, Roland Zauner, Verena Wally
{"title":"Repurposing diacerein for the treatment of chronic wounds in recessive-dystrophic epidermolysis bullosa patients by modulating matrix metalloproteinase-9 expression.","authors":"Sonja Dorfer, Michael Ablinger, Monika Wimmer, Julia I Hummel, Selma Ibrahimpašić, Anja Diem, Martin Laimer, Stefanie Gruner, Josefina Piñón Hofbauer, Christina Guttmann-Gruber, Ulrich Koller, Iris K Gratz, Johann W Bauer, Roland Zauner, Verena Wally","doi":"10.1111/1346-8138.17621","DOIUrl":"https://doi.org/10.1111/1346-8138.17621","url":null,"abstract":"<p><p>Recessive dystrophic epidermolysis bullosa (RDEB) is caused by mutations in COL7A1, leading to loss or dysfunction of type-VII collagen (C7), a protein essential for skin stability. Clinically, patients suffer from severe skin blistering, chronic or recurrent wounds, and scarring, which predispose to early onset of aggressive squamous cell carcinoma. Previous studies showed that RDEB-keratinocytes (RDEB-KC) express high levels of matrix-metalloproteinase 9 (MMP-9), a molecule known to play a crucial role in wound chronification if dysregulated. We investigated the potential of diacerein, a small molecule that interferes with the MMP-9 regulatory pathway, to improve wound healing in a 5-year old RDEB patient presenting with chronic, generalized skin involvement unresponsive to previous treatment approaches. Upon 4 weeks of topical therapy applied to the patient's back, parents reported a nearly complete wound closure and a significant increase in quality of life. We also provide evidence that diacerein treatment of patient keratinocytes results in a downregulation of MMP-9 expression, accompanied by a reduction in their ability to degrade a fibrinogen matrix. These data characterize diacerein as a potential candidate for improving wound healing in RDEB through its impact on inflammatory as well as epithelial cells.</p>","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143034345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of localized scleroderma with variable response to excimer light therapy. 准分子光治疗对局部硬皮病的可变反应1例。
The Journal of dermatology Pub Date : 2025-01-21 DOI: 10.1111/1346-8138.17635
Kyoko Kimura, Takeshi Fukumoto, Akiharu Kubo
{"title":"A case of localized scleroderma with variable response to excimer light therapy.","authors":"Kyoko Kimura, Takeshi Fukumoto, Akiharu Kubo","doi":"10.1111/1346-8138.17635","DOIUrl":"https://doi.org/10.1111/1346-8138.17635","url":null,"abstract":"","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143019166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term follow-up of sweat-gland carcinoma with neuroendocrine differentiation (SCAND) with sentinel lymph node metastases. 前哨淋巴结转移伴神经内分泌分化(SCAND)的汗腺癌的长期随访。
The Journal of dermatology Pub Date : 2025-01-21 DOI: 10.1111/1346-8138.17620
Masahito Yasuda, Setsuko Sasahira, Etsuko Okada, Atsushi Tamura, Osamu Ishikawa, Keisuke Goto, Yoji Kukita, Keiichiro Honma, Sei-Ichiro Motegi
{"title":"Long-term follow-up of sweat-gland carcinoma with neuroendocrine differentiation (SCAND) with sentinel lymph node metastases.","authors":"Masahito Yasuda, Setsuko Sasahira, Etsuko Okada, Atsushi Tamura, Osamu Ishikawa, Keisuke Goto, Yoji Kukita, Keiichiro Honma, Sei-Ichiro Motegi","doi":"10.1111/1346-8138.17620","DOIUrl":"https://doi.org/10.1111/1346-8138.17620","url":null,"abstract":"","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143019301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of psoriasiform drug eruption revealed by a drug-induced lymphocyte stimulation test. 药物性淋巴细胞刺激试验显示银屑病样药疹1例。
The Journal of dermatology Pub Date : 2025-01-21 DOI: 10.1111/1346-8138.17638
Satoshi Takeuchi, Yasuko Shiomichi, Takeshi Nakahara
{"title":"A case of psoriasiform drug eruption revealed by a drug-induced lymphocyte stimulation test.","authors":"Satoshi Takeuchi, Yasuko Shiomichi, Takeshi Nakahara","doi":"10.1111/1346-8138.17638","DOIUrl":"https://doi.org/10.1111/1346-8138.17638","url":null,"abstract":"","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143019208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Buruli ulcer with eccrine squamous syringometaplasia mimicking squamous cell carcinoma. 布鲁里溃疡伴酷似鳞状细胞癌的胰腺鳞状淋巴管化生。
The Journal of dermatology Pub Date : 2025-01-21 DOI: 10.1111/1346-8138.17637
Yoshimichi Kobayashi, Toshifumi Takahashi, Yasuaki Ikuno, Hiraku Kokubu, Akihiko Yamaguchi, Yoshihiko Hoshino, Akiko Arakawa, Noriki Fujimoto
{"title":"Buruli ulcer with eccrine squamous syringometaplasia mimicking squamous cell carcinoma.","authors":"Yoshimichi Kobayashi, Toshifumi Takahashi, Yasuaki Ikuno, Hiraku Kokubu, Akihiko Yamaguchi, Yoshihiko Hoshino, Akiko Arakawa, Noriki Fujimoto","doi":"10.1111/1346-8138.17637","DOIUrl":"https://doi.org/10.1111/1346-8138.17637","url":null,"abstract":"","PeriodicalId":94236,"journal":{"name":"The Journal of dermatology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143019281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信